Addressing Treatment Disparities to Reduce Risk and Improve Cardiovascular Outcomes Among Women and People of Color: A Spotlight on LDL-C Lowering

Faculty

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI

Director of Mount Sinai Heart Icahn School of Medicine at Mount Sinai

Erin D. Michos, MD, MHS

Associate Director of Preventive Cardiology
Division of Cardiology
Johns Hopkins University School of Medicine Co-Editor in Chief of the American Journal of Preventive Cardiology

Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA

Gerald S. Berenson Endowed Chair in Preventative Cardiology Professor of Medicine
John W. Deming Department of Medicine Tulane University School of Medicine

Kevin C Maki, PhD

President and Chief Scientist, Midwest Biomedical
Research
Adjunct Professor
Dean’s Eminent Scholar
Indiana University School of Public Health President
National Lipid Association (2022-2023)

Program Overview

Cardiovascular diseases (CVDs) remain a formidable global health challenge, claiming a significant portion of lives annually and imposing substantial economic burdens. Despite advancements in treatment and prevention, persistent disparities in awareness and access to care disproportionately affect women and individuals from diverse racial and ethnic backgrounds. This initiative aims to address these gaps by providing healthcare professionals with updated educational resources and insights from ongoing clinical trials to optimize prevention and treatment strategies.

Target Audience

This educational initiative is designed for healthcare professionals who provide primary prevention services to patients with dyslipidemia, including primary care clinicians (physicians, physician assistants, nurse practitioners), cardiologists, lipid specialists, endocrinologists and diabetologists.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Identify factors contributing to risk of atherosclerotic cardiovascular disease (ASCVD) in women and people from various racial/ethnic groups
  • Describe reasons for lower rates of hypercholesterolemia treatment and control in women and people from various racial/ethnic groups
  • Apply the clinical trial data, guidelines, and new indications for the use of non-statin treatments in appropriate patients
  • Apply shared decision-making strategies when counseling women and patients from various racial/ethnic populations on appropriate lipid-lowering therapies to reduce their risk of ASCVD

Educational Activities

Broadcasts
Podcasts
Threads
Clinical Resource Center

BROADCAST ONE

Credit Amount: 0.25
Credit Type: AMA
Expiration: 5/14/2025

BROADCAST TWO

Credit Amount: 0.25
Credit Type: AMA
Expiration: 5/15/2025

PODCAST ONE

Credit Amount: 0.25
Credit Type: AMA
Expiration: 5/14/2025

PODCAST TWO

Credit Amount: 0.25
Credit Type: AMA
Expiration: 5/16/2025

THREADS ONE

Credit Amount: 0.25
Credit Type: AMA
Expiration: 5/14/2025

THREADS TWO

Credit Amount: 0.25
Credit Type: AMA
Expiration: 5/16/2025

Clinical Resource Center

This activity is jointly provided by Global Education Group and Iridium Continuing Education.

SUPPORTER ACKNOWLEDGEMENT
This educational activity is supported by an independent educational grant from Esperion.

Maximum Credit Amount: 1.50
Credit Type: AMA
Release: May 14, 2024
Expiration: May 16, 2025

info@iridiumce.com